Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery

References

• Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358(23):2482–2494.
   PubMed Web of Science ®Google Scholar
• Deshmukh TB, Deo SS, Inam F, et al. Development and validation of ondansetron hydrochloride in pharmaceutical dosage form by RP-HPLC method. Int J Adv Sci Eng Technol. 2015;(Special Issue-1):15–20.
   Google Scholar
• Bitter C, Suter-Zimmermann K, Surber C. Nasal drug delivery in humans. Curr Probl Dermatol. 2011;40:20–35.
   PubMedGoogle Scholar
• Nasir A, Harikumar S, Amanpreet K. Niosomes: an excellent tool for drug delivery. Int J Res Pharm Chem. 2012;2(2):479–487.
   Google Scholar
• Vyshnavi V, Indira S, Srinivas P. Formulation and evaluation of nasal niosomal in situ gels of loratadine. Int J Pharm Sci Drug Res. 2015;7:13–21.
   Google Scholar
• Popli H, Nair MS. Niosomal delivery of tenoxicam. Indian J Pharm Sci. 1996;58(4):163.
   Google Scholar
• Tangri P, Khurana S. Niosomes: formulation and evaluation. Int J Biopharm. 2011;2(1):47–53.
   Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11(3):1119–1127.
   PubMed Web of Science ®Google Scholar
• Teaima MH, Abdelhalim SA, El-Nabarawi MA, et al. Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation. Drug Dev Ind Pharm. 2018;44(1):158–171.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9(3):740–747.
   PubMed Web of Science ®Google Scholar
• Jyoti K, Pandey RS, Madan J, et al. Inhalable cationic niosomes of curcumin enhanced drug delivery and apoptosis in lung cancer cells. Indian J Pharm Edu Res. 2017;50:S21–S31.
   Web of Science ®Google Scholar
• Jug M, Hafner A, Lovrić J, et al. In vitro dissolution/release methods for mucosal delivery systems. ADMET DMPK. 2017;5(3):173–182.
   Google Scholar
• D’Souza S. A review of in vitro drug release test methods for nano-sized dosage forms. Adv Pharm. 2014;2014:1–12.
   Google Scholar
• Ammar H, Haider M, Ibrahim M, et al. In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration. Drug Deliv. 2017;24(1):414–421.
   PubMed Web of Science ®Google Scholar
• Patil S, Dhage A, Patil S, et al. Formulation and evaluation of nasal in situ gel for Alzheimer’s disease. Int Res J Pharma Bio Sci. 2015;2(2):41–58.
   Google Scholar
• Majithiya RJ, Ghosh PK, Umrethia ML, et al. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech. 2006;7(3):E80–E86.
   Web of Science ®Google Scholar
• Ibrahim E-S, Ismail S, Fetih G, et al. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application. Acta Pharm. 2012;62(1):59–70.
   PubMed Web of Science ®Google Scholar
• Yong CS, Choi JS, Quan Q-Z, et al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm. 2001;226(1–2):195–205.
   PubMed Web of Science ®Google Scholar
• Appasaheb PS, Manohar SD, Bhanudas SR. Design, development and evaluation of in situ nasal mucoadhesive gel of metoprolol succinate by using guar gum as a natural mucoadhesive polymer. Metabolism. 2014;5:6.
   Google Scholar
• Bagul U, Gujar K, Dhat S, et al. In vitro study of mucoadhesive strength of polymers for mucoadhesive drug delivery systems. Int J Curr Pharm Res. 2009;1:42–46.
   Google Scholar
• Shah RA, Mehta MR, Patel DM, et al. Design and optimization of mucoadhesive nasal in situ gel containing sodium cromoglycate using factorial design. Asian J Pharm. 2011;5(2):65.
   Google Scholar
• Kumar MV, Aravindram A, Rohitash K, et al. Formulation and evaluation of in situ gel of bromhexine hydrochloride for nasal delivery. Pharm Sin. 2012;3:699–707.
   Google Scholar
• Ghada A, Abdel Bary A, Boseila AA. Preparation and characterization of thermosensitive mucoadhesive in situ gels for nasal delivery of ondansetron hydrochloride. AZ J Pharm Sci. 2014;50(2):191–207.
   Google Scholar
• Bauer S, Störmer E, Kaiser R, et al. Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection. Biomed Chromatogr. 2002;16(3):187–190.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services FaDA. USFDA. Guidance for industry: bioanalytical method validation; 2001. Available from: https://www.gmp-compliance.org/guidemgr/files/ucm070107.pdf
   Google Scholar
• Suneetha A, Donepudi S. HPLC method development and validation for the estimation of Axitinib in rabbit plasma. Braz J Pharm Sci. 2017;53(3).
   Web of Science ®Google Scholar
• Sheshala R, Khan N, Chitneni M, et al. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res. 2011;34:1945–1956..
   PubMed Web of Science ®Google Scholar
• Charlton S, Jones N, Davis S, et al. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device. Eur J Pharm Sci. 2007;30(3-4):295–302.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244(1–2):73–80.
   PubMed Web of Science ®Google Scholar
• Singh CH, Jain C, Kumar BN. Formulation, characterization, stability and in vitro evaluation of nimesulide niosomes. Pharmacophore. 2011;3(168):e185.
   Google Scholar
• Baillie A, Coombs G, Dolan T, et al. Non‐ionic surfactant vesicles, niosomes, as a delivery system for the anti‐leishmanial drug, sodium stibogluconate. J Pharm Pharmacol. 1986;38(7):502–505.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Farghaly U, Moharram H. Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharm Investig. 2014;44(5):329–337.
   Google Scholar
• Darwish A. Increasing the activity and safety of the anti-inflammatory drug lornoxicam via niosomal encapsulation. 2016. Pages 13,14. Published in Cairo University Theses.
   Google Scholar
• Nie S, Hsiao WW, Pan W, et al. Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies . Int J Nanomedicine. 2011;6:151–166.
   PubMed Web of Science ®Google Scholar
• Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–223.
   PubMed Web of Science ®Google Scholar